KERRI SELF: Open Payments
NPI 1144005224 · PORTALES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $278 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $102 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Alkermes, Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $19 |
Products named: VRAYLAR, REXULTI, Auvelity, CAPLYTA, Qelbree, AUSTEDO XR, ARISTADA, INGREZZA.
Industry payments across NM — which companies pay providers there.
